BeneHeart D3 Mindray: Biphasic Defibrillator with ECG Monitoring, AED, and Cardiac Pacing for Hospitals and Clinics
The Mindray BeneHeart D3 defibrillator is a versatile medical device designed to deliver optimal performance in emergency situations. Compact, lightweight, and durable, this device integrates essential functions for managing cardiac arrest, such as manual defibrillation, AED (Automated External Defibrillator), cardiac pacing, and monitoring of vital signs, especially ECG and SpO2. This model is primarily intended for hospitals, clinics, and other healthcare facilities, where reliable and high-performance equipment is essential to respond quickly to cardiac emergencies.
One of the main advantages of the BeneHeart D3 is its 4-in-1 design, offering a complete solution for patient management in resuscitation. The semi-automatic mode allows for simplified use while ensuring a rapid and effective response to patients. The user only needs to follow three simple steps: select energy, charge, and then administer the shock. This intuitive interface allows clinicians to focus on patient care while saving valuable time.
In terms of performance, the BeneHeart D3 stands out with its defibrillation capacity, providing a shock power of up to 360 J, making it capable of treating a wide range of patients, including those with more complex cardiac electrical resistance. Thanks to its advanced biphasic technology and automatic impedance compensation, this defibrillator offers enhanced efficacy for resuscitating difficult-to-defibrillate patients, thus increasing the chances of survival in cases of cardiac arrest.
Another major advantage of this defibrillator is its powerful and reliable battery. It allows for up to 200 shocks at 360 J, while also providing 6 hours of continuous monitoring, ensuring its effectiveness even during transport or in prolonged emergency situations. This feature is especially valuable in contexts where continuous access to an external power source is not possible.
The BeneHeart D3 is equipped with a bright 7-inch TFT screen, allowing healthcare professionals to easily view ECG curves and SpO2 levels. The clear and precise display of this information is crucial for rapid diagnosis and monitoring of the patient's condition. This integrated monitor also tracks other vital parameters, providing a comprehensive view of the patient’s status during the intervention.
The BeneHeart D3 is designed to ensure high reliability. It automatically performs daily and weekly self-tests, ensuring that the device is ready for use at any time. Additionally, these tests are sent to a central station via a 5G/2.4G WiFi connection, enabling efficient management of patient health data. It is compatible with the international IHE HL7 protocol and DHCP, making integration into existing hospital IT systems easy.
In terms of portability, the BeneHeart D3 stands out for its lightweight and compact design, making it especially suited for use in various clinical environments. It can be easily moved from one department to another while offering the safety and performance of a high-quality device. Its lightweight and reduced size also make it suitable for use in emergency situations outside healthcare facilities, such as in ambulances or during pre-hospital interventions.
Reliability, rapid intervention, and ease of use make the BeneHeart D3 an essential choice for healthcare facilities seeking a high-performance defibrillator that can effectively respond to cardiac emergencies. With its advanced technology, biphasic shock capability, and vital monitoring functions, the BeneHeart D3 provides healthcare professionals with a robust and intuitive device to save lives.
The Mindray BeneHeart D3 is more than just a defibrillator: it is a true emergency cardiac management tool, designed to meet the challenges of advanced resuscitation and patient monitoring in critical situations. Its cutting-edge technology, ease of use, high shock capacity, and compact design make it an invaluable ally in modern healthcare facilities, ensuring optimal care for patients in cardiac arrest.
